Matches 1 - 50 out of 172 1 2 3 4 >


Match Document Document Title
US20110301240 CONDITIONING COMPOSITION  
The present invention is directed to a composition for the conditioning of a dental mineralized surface and/or a dental implant and/or for increasing the hydrophilicity of a dental implant having...
US20110038953 STRONTIUM COMPOUND FOR TREATMENT OF SUB-DERMAL SOFT TISSUE PAIN  
The invention provides a method of treatment of a human or non-human subject to combat sub-dermal soft tissue pain therein, said method comprising administering to a subject in need thereof an...
US20120189493 ANTI-MICROBIAL SYSTEMS AND METHODS  
An antimicrobial system. When generally formulated to disinfect a catheter, the antimicrobial substance comprises water and between approximately 10 and 200 mg of tetrasodium EDTA for each...
US20130315981 METHOD FOR INDUCING FAT LOSS IN MAMMALS  
The present invention is a method of increasing lipolysis in an adipose tissue of a mammal comprising delivering to macrophages at the adipose tissue of the mammal an effective amount of an agent...
US20110003013 METHOD OF INCREASING METABOLISM  
The present invention provides a method for increasing metabolism and/or energy expenditure in a subject, e.g., to treat or prevent obesity and/or a related condition and/or to reduce adiposity,...
US20100324132 METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING  
The present invention provides methods and compositions that use the combination of Tris and EDTA to inhibit the growth of microorganisms at the site of a wound or burn, and/or to promote the...
US20110152213 RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES  
It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the...
US20120071559 METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG  
Methods of quantifying a N2-carboxyethyl-2′-deoxyguanosine (CEdG) levels in biological samples and comparing those levels to known normal levels can diagnose a number of disorders, including...
US20060276541 Fruit, vegetable, and seed disinfectants  
Antimicrobial formulations are described that can be used to reduce levels of microbes on the surfaces of plants and plant parts.
US20100069335 Prevention and Treatment of Ophthalmic Complications of Diabetes  
An method and formulation are provided for the prevention and treatment of adverse ocular conditions which are complications of diabetes. In one embodiment, the invention comprises administering...
US20140271825 PHARMACEUTICAL FORMULATIONS OF CHELATING AGENTS AS A METAL REMOVAL TREATMENT SYSTEM  
The present invention provides liposomes loaded with chelating agents, pharmaceutical formulations including these liposomes and methods of making chelating agent liposomes. Because the chelating...
US20110206638 COMPOSITIONS AND METHODS FOR REDUCING THE MUTATION RATE OF VIRUSES  
The disclosure provides compositions and methods for reducing the mutation rate of a virus, such as an RNA virus or a DNA virus, in a cell infected with the virus by, in one aspect, contacting the...
US20120046226 Combined Treatment of Multiple Sclerosis  
The invention concerns a novel treatment multiple sclerosis, based on induced anaemia, followed by administration of an erythropoiesis-stimulating agent (ESA). In a preferred embodiment, the ESA...
US20070265339 STORAGE-STABLE AQUEOUS COMPOSITION COMPRISING A MAGNESIUM COMPOUND AND L-CARNITINE  
The present invention relates to a storage-stable aqueous or gel-like composition or solution comprising a magnesium compound selected from a magnesium salt or a magnesium complex compound, and...
US20070270355 Sport drink containing amino acids and carbohydrates  
A composition includes a plurality of amino acids. The plurality of amino acids includes at least one essential amino acid and at least one non-essential amino acid. The plurality of amino acids...
US20070293428 Methods of treating joint pain in a subject by using an anti-angiogenic agent  
A method for treating a joint pain in a subject comprising providing an effective amount of an anti-angiogenic agent to a synovial capsule adjacent to the joint.
US20100310460 COMPOSITIONS AND METHODS FOR CHELATION THERAPY  
The invention relates to compositions and methods of treatment using an iron chelator, an antioxidant, estrogen, and/or combinations thereof, optionally, linked to a nanoparticle, to treat a...
US20050042280 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol  
The present invention is directed to aqueous based formulations of water-soluble prodrugs of propofol. The formulations comprise in aqueous medium an effective amount of the water-soluble prodrug...
US20070191368 Inhibition of tissue damage to skin from radiation treatment therapy  
A method of and composition for inhibiting the deleterious effects on mammalian skin tissue by radiation treatment therapy comprising administering to a patient in need thereof, in conjunction...
US20140275260 Preparation Of Stable Pharmaceutical Dosage Forms  
The invention provides a process for preparing stable, high API content, solid pharmaceutical dosage forms by direct compression or dry granulation, characterized in that the pharmaceutical...
US20110311602 TRANSDERMAL VENOUS ACCESS LOCKING SOLUTIONS  
Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the...
US20150079203 ANTIMICROBIAL COMPOSITIONS  
Antimicrobial compositions providing synergistic antimicrobial effects against a variety of bacterial, viral and fungal organisms are described. Methods for using the antimicrobial compositions...
US20150140113 GELLING AGENT-BASED DOSAGE FORM  
The present invention generally relates to dosage forms for oral administration including one or more gelling agents. In particular, the present invention is directed to gelling agent-based dosage...
US20070105942 Supplemental dietary composition for turning on anabolic switches in muscle, stimulating and/or optimizing protein synthesis, and/or potently signaling muscle building and/or growth via molecular pathways  
Compositions and methods relating to the use of cationic and monobasic amino acids combined with ketoacids for the purposes of regulating molecular signals to control anabolic and anti-catabolic...
US20070027206 Iminocarboxylic acid salt-containing solid composition and production method thereof  
To provide a solid composition as follows: exhibiting excellent stability; having advantages for transportation and storage; containing no additives; exhibiting functions such as excellent...
US20120029418 COMPOSITION AND METHOD FOR PHOTODYNAMIC DISINFECTION  
The present invention includes a composition for photoablation comprising a photosensitizer and ethylenediaminetetraacetic acid (“EDTA”) at a very low concentration (e.g., ranging from about 0.01...
US20100222875 METHOD FOR FORMING A POROUS STENT COATING  
Methods for forming porous stent coatings are disclosed.
US20130310732 CORNEAL DELIVERY OF CROSS-LINKING AGENTS BY IONTOPHORESIS FOR THE TREATMENT OF KERATOCONUS AND RELATED OPHTHALMIC COMPOSITIONS  
Iontophoresis for delivering ophthalmic compositions (in particular. collyriums) preferably containing riboflavin, or other cross-linking agents, designed to imbibe the corneal stroma in the...
US20050209303 Method of treatment for high neurotransmitter pattern  
A person suffering from a high neurotransmitter pattern, as is characteristic with a patient diagnosed with ADD or ADHD, is treated by administering to the person an effective amount of:...
US20150105465 Antiseptic compositions, methods and systems  
Antiseptic compositions comprising at least one salt of EDTA are disclosed. These compositions have broad spectrum antimicrobial and antifungal activity and they also have anticoagulant...
US20140194519 Antiseptic compositions, methods and systems  
Antiseptic compositions comprising at least one salt of EDTA are disclosed. These compositions have broad spectrum antimicrobial and antifungal activity and they also have anticoagulant...
US20140194518 Antiseptic compositions, methods and systems  
Antiseptic compositions comprising at least one salt of EDTA are disclosed. These compositions have broad spectrum antimicrobial and antifungal activity and they also have anticoagulant...
US20140024719 Antiseptic compositions, methods and systems  
Antiseptic compositions comprising at least one salt of EDTA are disclosed. These compositions have broad spectrum antimicrobial and antifungal activity and they also have anticoagulant...
US20060025380 Formulations for non-parenteral use including hydrophobic cyclodextrins  
A novel system for non-parenteral formulations comprising cyclodextrins is disclosed. The system includes hydrophobic cyclodextrins and amino acids and homo- or co-polymers thereof. The...
US20060211631 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1  
The infusion preparation for peripheral parenteral administration comprises an infusion (A) containing glucose with 80 to 200 g/L concentration, and an infusion (B) containing amino acid with 50...
US20090149541 Method of delaying the onset of clinically definite multiple sclerosis  
A method for delaying the onset of clinically definite multiple sclerosis in a patient at risk of developing clinically definite multiple sclerosis and retard long-term progression of multiple...
US20070248690 Composition and methods for alleviating symptoms of neurotoxicity  
A composition for alleviating symptoms associated with neurotoxicity. The composition may comprise compounds for preventing glutamate mediated neurotoxicity. The composition may include one or...
US20130089602 ENCAPSULATED CHELATOR  
An enhanced chelator includes a chelating agent and a volatile material encapsulated in a biologically benign microcapsule. The enhanced chelator possesses significantly improved shelf-life in...
US20070086952 Rapid Acting and Prolonged Acting Inhalable Insulin Preparations  
It has been discovered that by combining a chelator, such as ethylenediaminetetraacetic acid, with an acidifier, such as citric acid, the insulin is absorbed much more rapidly than in the absence...
US20140314827 Antimicrobial compositions and uses therefor  
Described herein are compositions comprising at least one buffering agent, at least one chelating agent and at least one antimicrobial agent, which can be used for treating and/or preventing...
US20140186408 CRYSTAL POLYMORPH OF MAGNESIUM GLYCINATE DIHYDRATE AND PROCESS FOR ITS PREPARATION  
Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable...
US20150119442 Biocide agents against marine woodborers  
The present invention relates to biodegradable biocide agents against marine woodborers. In particular, the present invention relates to novel slow releasing biocide impregnating solutions against...
US20110213035 BIOCIDE AGENTS AGAINST MARINE WOODBORERS  
The present invention relates to biodegradable biocide agents against marine woodborers. In particular, the present invention relates to novel slow releasing biocide impregnating solutions against...
US20110189260 USE OF ZINC CHELATORS TO INHIBIT BIOFILM FORMATION  
A method is provided for inhibiting formation of a biofilm of bacteria, the method including contacting the bacteria with an effective amount of at least one zinc chelator, wherein the bacteria...
US20110152220 METHODS OF DIAGNOSING, PREVENTING AND TREATING BONE MASS DISEASES  
The present invention provides methods and therapeutic agents for lowering or increasing serum serotonin levels in a patient in order to increase or decrease bone mass, respectively. In preferred...
US20070065497 Combination and method using EDTA combined with glutathione in the reduced state encapsulated in a liposome to facilitate the method of delivery of the combination as an oral, topical, intraoral or transmucosal, for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy  
The invention is for the combination of EDTA and glutathione in the reduced state encapsulated in a liposome for prevention and therapy of coronary artery disease (CAD), and anti-thrombotic effect...
US20070281985 Infusion fluid for dialysis patients  
A pharmaceutical preparation including an amino acid infusion fluid is administered to patients receiving dialysis to ameliorate nutritional status of patients. As a result, anemia can be...
US20140275258 Chelation Suppository for Improved Drug Delivery  
Described herein is a method of delivering drugs to the blood stream directly by absorption through cell membranes in the wall of the rectum from a rectal suppository comprising a glyceride based...
US20140179741 USE OF CHELATORS OF DIVALENT CATIONS TO PROMOTE NERVE REGENERATION  
Disclosed herein are methods to promote axonal outgrowth of a neuron comprising, contacting the neuron with an effective amount of a chelating agent, to thereby promote axonal outgrowth in the...
US20050112200 EDTA containing compositions and uses thereof  
EDTA and EDTA related compositions and methods of using them are described herein. The compositions can have improved bioavailability over EDTA alone. The compositions can be useful in the...

Matches 1 - 50 out of 172 1 2 3 4 >